Announcements
- 2023.11.28 (1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE(S) TO HANDLE MATTERS PERTAINING TO THE H SHARE AWARD AND TRUST SCHEME; AND (4) THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 DISCLOSEABLE TRANSACTION PROPOSED SALE OF EQUITY INTEREST IN THE TARGET COMPANY
- 2023.11.28 (1) PROPOSED GRANTING OF REPURCHASE MANDATE TO REPURCHASE H SHARES; (2) PROPOSED ADOPTION OF THE H SHARE AWARD AND TRUST SCHEME; (3) PROPOSED AUTHORIZATION TO THE BOARD AND/OR THE DELEGATEE(S) TO HANDLE MATTERS PERTAINING TO THE H SHARE AWARD AND TRUST SCHEME; AND (4) THE 2023 SECOND EXTRAORDINARY GENERAL MEETING
- 2023.11.28 VOLUNTARY ANNOUNCEMENT ONE-YEAR RESULTS OF THE CONFIRMATORY CLINICAL TRIAL OF LUX-VALVE RELEASED AT THE PCR LONDON VALVES 2023
- 2023.11.13 SIMULOCK SUCCESSFULLY COMPLETES IMPLANTATION SURGERY FOR THE FIRST CONFIRMATORY CLINICAL TRIAL
- 2023.11.03 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
- 2023.10.31 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS TRAVEL II RESULTS RELEASED AT THE 2023 TCT IN THE U.S.
- 2023.10.30 VOLUNTARY ANNOUNCEMENT KEN-VALVE REGISTRATION APPLICATION ENTERS NMPA PRIORITY APPROVAL PROCESS
- 2023.10.20 VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SUCCESSFULLY COMPLETES A SERIES OF FEE-FOR-SERVICE COMPASSIONATE USE TREATMENTS IN THE ASIA-PACIFIC REGION
- 2023.10.19 VOLUNTARY ANNOUNCEMENT RELEASE OF THE RESULTS OF THE MULTICENTER CLINICAL TRIAL OF LUX-VALVE PLUS AT THE 2023 TCT IN THE U.S.
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
